NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 CubeSmart Q1 2026 Earnings Slight EPS Beat Amid Steady SelfStorage Demand Keysight Technologies Q1 2026 Earnings Strong EPS Beat of 212 Amid Revenue Uncertainty Design Therapeutics Inc DSGN Q1 2026 Earnings Narrower Loss Surpasses Expectations Amid Quiet Quarter IOBT Q1 2025 Earnings Beating Estimates While Advancing Pipeline Milestones MSFT Q1 2026 Earnings Solid EPS Beat Offsets Modest Revenue Headwinds